Under construction – not a live service
Sign in
Taking people in PakistanNo phase

Two breathing exercises compared in adults with bronchial asthma

Compares alternate nostril breathing with Buteyko breathing in adults with asthma.

Plain-language title generated from the registry record
Registry title: Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma

Key facts

Where
Islamabad, PakistanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT07529847, who can take part

Where in Pakistan

  • Foundation University, IslamabadIslamabad, PakistanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Foundation University Islamabad
Trial code
NCT07529847
Record updated
14 April 2026
Original description
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation.Read full original descriptionShow less

Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma

Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation.

Dysfunctional breathing pattern and chronic hyperventilation

Inclusion: Age between 18-45 years; Both genders (male and female); Grade 1-3 on mMRC scale of dyspnea; Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020).

Exclusion: Patients diagnosed with acute infection; Patients having acute exerbation of COPD/status asthmaticus; Patients unable to follow command and instructions; Asthma patients with >40sec control pause duration.

ClinicalTrials.gov NCT07529847